Centene stock slides as Bank of America Securities issues downgrade
In a note, Research Analyst Kevin Fischbeck expressed concern about Medicaid redeterminations, recent setbacks and possible future ones on contracts to run Medicaid managed care programs in states, and a poor rating from the federal government on Centene's Medicare Advantage plan.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: James Drew Source Type: news
More News: Contracts | Government | Health Management | Managed Care | Medicaid | Medicare | Pharmaceuticals